Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Talk Speech Pathology is an Australian pediatric speech pathology and allied health services provider operating across Adelaide and the Fleurieu Peninsula in South Australia. The company focuses on assessment and therapy for children with speech, language, literacy, social communication, fluency, and feeding-related needs. Its services are delivered in clinics, preschools, schools, and homes, and the practice emphasizes evidence-based care and family-centered support. Talk has been operating since 2000 and appears to function as a private clinical services business rather than a biotech, pharma, or therapeutics developer. There is no evidence that the company has a drug pipeline, therapeutic platform, or R&D-stage life sciences programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Talk Speech Pathology.